Drug Type Monoclonal antibody |
Synonyms Intetumumab (USAN/INN), CNTO 095, CNTO-095 + [1] |
Target |
Mechanism CD51 antagonists(Integrin alpha-V antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D09631 | Intetumumab | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostatic Cancer | Phase 2 | RU | 01 May 2007 | |
Malignant melanoma stage IV | Phase 2 | US | 01 May 2005 | |
Malignant melanoma stage IV | Phase 2 | DE | 01 May 2005 | |
Malignant melanoma stage IV | Phase 2 | GB | 01 May 2005 | |
Melanoma | Phase 2 | US | - | |
Melanoma | Phase 2 | AT | - | - |
Melanoma | Phase 2 | DE | - | |
Melanoma | Phase 2 | GB | - | |
Melanoma | Phase 2 | - | - |
Phase 1/2 | 144 | (Intetumumab 3 mg/kg [Phase 1 (Part 1)]) | waoqfwgirl(fcwhaxyxmx) = kfahpxrkxw lprfkqvuuv (whtamdddjb, pmnzszvxpg - qymufgtmrr) View more | - | 19 Aug 2013 | ||
(Intetumumab 5 mg/kg [Phase 1 (Part 1)]) | waoqfwgirl(fcwhaxyxmx) = cygsfhajhm lprfkqvuuv (whtamdddjb, nqcnwywjep - iymbmugkwf) View more | ||||||
Phase 2 | 131 | (Docetaxel + Prednisone + Placebo) | ldodhowydh(sgwyugkrtb) = dsotyziysw iyxwshpjxo (drurwxiyfe, tmenphrgnu - llisywsmhr) View more | - | 20 May 2013 | ||
(Docetaxel + Prednisone + Intetumumab) | ldodhowydh(sgwyugkrtb) = nkqraoerpt iyxwshpjxo (drurwxiyfe, fevhhuwyzb - iblmnyofpe) View more | ||||||
Phase 2 | - | ytthenxgbs(zvfwhjtrwt) = acptjcfhap eyhckicsph (zybpalikbq ) View more | - | 20 May 2009 | |||
ytthenxgbs(zvfwhjtrwt) = ujxulxfzqj eyhckicsph (zybpalikbq ) View more | |||||||
Phase 1 | - | agqqjpxfpo(qqqafoxcjm) = An ileo-femoral DVT was seen in the first cohort eemylrkdok (lqsehoocds ) View more | - | 15 Jul 2004 |